Paradigm BioCapital Advisors LP 13D and 13G filings for Vor Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:33 pm Sale |
2024-09-30 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 0 0.000% |
-6,457,293 (Position Closed) |
Filing |
| 2024-02-14 4:08 pm Sale |
2023-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,457,293 9.500% |
-20,706 (-0.32%) |
Filing |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 6,477,999 9.900% |
4,149,505 (+178.21%) |
Filing |
| 2022-10-27 4:47 pm Purchase |
2022-10-17 | 13G | Vor Biopharma Inc. VOR |
Paradigm BioCapital Advisors LP | 2,328,494 6.100% |
2,328,494 (New Position) |
Filing |